Page last updated: 2024-08-26

rubidium and 2,2,5,7,8-pentamethyl-1-hydroxychroman

rubidium has been researched along with 2,2,5,7,8-pentamethyl-1-hydroxychroman in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunlop, J; Jow, F; Kowal, D; Maddox, T; Mekonnen, B; Shen, R; Tseng, E; Wang, K1

Other Studies

1 other study(ies) available for rubidium and 2,2,5,7,8-pentamethyl-1-hydroxychroman

ArticleYear
Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
    Assay and drug development technologies, 2006, Volume: 4, Issue:4

    Topics: Animals; Anthracenes; Benzodiazepines; CHO Cells; Chromans; Cricetinae; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gene Expression; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; KCNQ1 Potassium Channel; Long QT Syndrome; Membrane Potentials; Myocardium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Potassium Chloride; Rats; Reproducibility of Results; Risk Factors; Rubidium; Spectrophotometry, Atomic; Tetraethylammonium

2006